Provided by Tiger Trade Technology Pte. Ltd.

Bristol-Myers Squibb

64.04
+0.31000.49%
Volume:2.27M
Turnover:145.43M
Market Cap:130.37B
PE:14.10
High:64.38
Open:64.07
Low:63.60
Close:63.73
52wk High:68.64
52wk Low:42.52
Shares:2.04B
Float Shares:2.03B
Volume Ratio:0.54
T/O Rate:0.11%
Dividend:2.51
Dividend Rate:3.92%
EPS(TTM):4.54
EPS(LYR):3.46
ROE:46.60%
ROA:10.72%
PB:5.84
PE(LYR):18.51

Loading ...

Bloomsbury Executives Adjust Holdings After 2023 Share Plan Vesting

TIPRANKS
·
Sep 10

HSBC Adjusts Price Target on Bristol-Myers Squibb to $65 From $60, Keeps Hold Rating

MT Newswires Live
·
Sep 10

Scotiabank Keeps Their Hold Rating on Bristol-Myers Squibb (BMY)

TIPRANKS
·
Sep 09

Analysts Have Conflicting Sentiments on These Healthcare Companies: Bristol-Myers Squibb (BMY), Stryker (SYK) and InnovAge Holding (INNV)

TIPRANKS
·
Sep 09

CD&R Appoints Novartis Chair Giovanni Caforio Operating Advisor to Funds

Reuters
·
Sep 09

Bristol Myers Squibb Co. Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Sep 09

Bristol-Myers Squibb Co Stock (BMY) Moved Down by 3.25% on Sep 8: Facts Behind the Movement

TradingKey
·
Sep 09

Movement Alert|Bristol-Myers Squibb Falls 3.05% in Regular Trading, CAR-T Safety Concerns Across Sector Offset Positive Clinical Data

Market Focus
·
Sep 08

Bristol Myers Squibb's Phase 2 Study of Arlocabtagene Autoleucel Meets Key Endpoints

MT Newswires Live
·
Sep 08

Bristol Myers’ arlocabtagene autoleucel shows positive results in Phase 2 trial

TIPRANKS
·
Sep 08

Bristol Myers Squibb's Therapy Meets Mid-Stage Trial Goal

Reuters
·
Sep 08

Bristol Myers Squibb Announces Positive Topline Results from Registrational Phase 2 Quintessential Trial of the Potential First-in-Class Gprc5d-Directed Car T Cell Therapy, Arlocabtagene Autoleucel ...

THOMSON REUTERS
·
Sep 08

Bristol-Myers Squibb Company - Phase 2 Trial Met Primary Endpoint of Overall Response Rate and Complete Response Rate

THOMSON REUTERS
·
Sep 08

Bristol-Myers Squibb Company - Arlo-Cel Safety Profile Consistent with Other Car T Cell Therapies

THOMSON REUTERS
·
Sep 08

Jeito Capital Promotes Pascal Touchon to Partner

Reuters
·
Sep 08

Berenberg Bank Sticks to Its Buy Rating for Bloomsbury Publishing (BMY)

TIPRANKS
·
Sep 08

Bristol Myers Squibb Co. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Sep 05

Bristol-Myers Squibb Moves Into Depression Market With New Phase 2 Trial

TIPRANKS
·
Sep 05

Drugmakers Halt Autoimmune Trials After Deaths, Life-Threatening Side Effects

Dow Jones
·
Sep 04

Market Chatter: Bristol Myers Squibb Paused Zola-Cel Trials Over Safety Concerns

MT Newswires Live
·
Sep 04